bit.bio is an award-winning human synthetic biology enterprise based in Cambridge, UK. bit.bio's mission is to code cells for health. Our breakthrough opti-ox technology platform is capable of producing consistent batches of every human cell. The technology directly reprograms stem cells into other human cell types with consistency at scale.
Wednesday, 18th November, 2020
10:00am GMT (UTC+0)
hosted by Lilly Xu, Ph.D. Senior Vice President, DMPK & Exploratory Toxicology Dept, ChemPartner